CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures.
暂无分享,去创建一个
[1] Raphael Kopan,et al. Real-Time Imaging of Notch Activation with a Luciferase Complementation-Based Reporter , 2011, Science Signaling.
[2] Igor Jurisica,et al. Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment , 2011, Science.
[3] H. Nakauchi,et al. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment , 2010, The Journal of experimental medicine.
[4] Ryan Brinkman,et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. , 2007, Cell stem cell.
[5] B. Porse,et al. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.
[6] I. Bernstein,et al. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. , 2005, Blood.
[7] K. Jones,et al. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. , 2004, Molecular cell.
[8] W. Vainchenker,et al. Membrane-bound Delta-4 Notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potential , 2004, Leukemia.
[9] S. Ferrari,et al. Functional and kinetic characterization of granulocyte colony‐stimulating factor‐primed CD34− human stem cells , 2003, British journal of haematology.
[10] S. Ikehara,et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. , 2003, Blood.
[11] K. Ando,et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. , 2003, Blood.
[12] G. Seitz,et al. Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. , 2003, Blood.
[13] M. Simon,et al. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] Karine Hovanes,et al. β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer , 2001, Nature Genetics.
[15] R. Mulligan,et al. Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. , 2000, Blood.
[16] K. Ando,et al. Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. , 1999, Blood.
[17] J. Dick,et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity , 1998, Nature Medicine.
[18] M. Ogawa,et al. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. , 1998, Experimental hematology.
[19] R. Johnson,et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.
[20] F. Rosenbauer,et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.
[21] J. Nolta,et al. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. , 2003, Blood.
[22] Transforming growth factor (cid:1) -induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation , 2022 .